Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$3.6 million.

  • Palisade Bio's Free Cash Flow fell 1340.57% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year increase of 1970.06%. This contributed to the annual value of -$12.2 million for FY2024, which is 948.19% down from last year.
  • Palisade Bio's Free Cash Flow amounted to -$3.6 million in Q3 2025, which was down 1340.57% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Palisade Bio's Free Cash Flow peaked at -$1.2 million during Q1 2021, and registered a low of -$3.8 million during Q1 2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$3.1 million (2022), whereas its average is -$2.9 million.
  • As far as peak fluctuations go, Palisade Bio's Free Cash Flow plummeted by 20112.0% in 2022, and later skyrocketed by 4807.09% in 2025.
  • Quarter analysis of 5 years shows Palisade Bio's Free Cash Flow stood at -$1.2 million in 2021, then tumbled by 165.28% to -$3.3 million in 2022, then grew by 17.19% to -$2.7 million in 2023, then grew by 13.29% to -$2.4 million in 2024, then plummeted by 49.22% to -$3.6 million in 2025.
  • Its Free Cash Flow stands at -$3.6 million for Q3 2025, versus -$1.8 million for Q2 2025 and -$2.3 million for Q1 2025.